Dimitris Mavroudis

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Galatea Kallergi, Maria A. Papadaki, Eleni Politaki et al. · Breast Cancer Research · 2011 · 373 citations · Full text

Medicine, Cell Biology, Oncology +17

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Panayiotis A. Theodoropoulos, Hara Polioudaki, Sofia Agelaki et al. · Cancer Letters · 2009 · 286 citations

Medicine, Cell Biology, Oncology +17

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

N. Xenidis, Maria Perraki, Maria Kafousi et al. · Journal of Clinical Oncology · 2006 · 265 citations · Full text

Medicine, Oncology, Breast Oncology +12

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Nikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki et al. · Journal of Clinical Oncology · 2009 · 241 citations · Full text

Medicine, Cancer Biology, Oncology +15